Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project. — CFSMEATLAS
E2 ModerateModerate confidencePEM not requiredCase-ControlPeer-reviewedMachine draft
Standard · 3 min
Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project.
Midenfjord, Irina, Khadija, Mahrukh, Sundelin, Elias et al. · United European gastroenterology journal · 2026 · DOI
Quick Summary
This study looked at 607 patients with irritable bowel syndrome (IBS) across nine European centers to understand how other conditions—like anxiety, depression, fibromyalgia, and chronic fatigue syndrome—affect their symptoms and overall health. Patients who had IBS along with one or more of these comorbid conditions experienced more severe digestive symptoms, mood problems, and fatigue than those with IBS alone. The more comorbidities someone had, the worse their symptoms became.
Why It Matters
This study is significant for ME/CFS patients because it rigorously demonstrates that comorbid conditions substantially worsen symptom severity and disease burden, validating the clinical experience of patients with multiple overlapping conditions. The inclusion of chronic fatigue syndrome as a comorbidity and the large multinational cohort design strengthen the evidence base for understanding how ME/CFS co-occurring with other conditions affects patient outcomes and care needs.
Observed Findings
IBS patients with comorbid conditions experienced significantly more severe IBS, anxiety, depression, somatic symptoms, and fatigue compared to IBS patients without comorbidities.
Symptom severity increased in a dose-dependent manner with the number of comorbidities present (p < 0.001).
607 IBS patients were recruited from nine European centers between March 2021 and January 2023.
Fibromyalgia and chronic fatigue syndrome were identified as prevalent somatic comorbidities in this IBS population.
Psychiatric and somatic comorbidities significantly amplify disease burden and symptom severity in IBS patients.
The presence of multiple comorbidities creates a cumulative negative effect on symptom outcomes, suggesting a dose-response relationship.
Clinical assessment and management of IBS should systematically screen for and address comorbid psychiatric and somatic conditions.
Remaining Questions
What are the underlying biological or pathophysiological mechanisms linking IBS, psychiatric disorders, fibromyalgia, and chronic fatigue syndrome?
What This Study Does Not Prove
This study does not establish whether comorbidities cause worsening of IBS symptoms or whether underlying shared biological mechanisms link these conditions. The cross-sectional design cannot determine temporal relationships or directionality—it only shows that these conditions co-occur and are associated with greater severity. The study also does not identify specific mechanisms explaining why comorbidities increase symptom burden.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →